Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
BiogenProduct Development and Commercialization Lead - Stroke
Dec. 2021Cambridge, Massachusetts, United States• Lead the cross-functional (including R&D, PO&T, Medical, Commercial, Finance, and legal etc.) Product Development and Commercialization (PDC) Teams to develop and execute the product development and commercialization strategy for two stroke programs (Large Hemispheric Infarction and Acute Ischemic Stroke)
•Develop and execute clinical development programs and lifecycle management plans, including data generation, label creation, and LRP-driving opportunities.
•Partner with Global Finance to develop long-range plans (ie 15 year plans), annual operating plans, and assess business opportunities.
•Define and drive the business goals for the products; deliver high-quality brand strategic plans for the business.
•Work with regions to ensure alignment to launch strategy and forecast assumptions.
•Navigate with senior levels of the organization and cultivate relationships to solve unprecedented challenges, secure resources, and commit for key functional initiatives.
•Partner with (and hold accountable) all functions contributing to product development and commercialization.
•Key author, presenter, and contributor to the Disease Area Strategic Plan.
•Accountability to the program finances to recommend business investments.
•Develop geographic expansion.
Accountable for a comprehensive assessment of current and future competition and identifying opportunities to guide/refine the global development and commercialization strategy amidst rapidly changing market dynamics.
•Identify future market dynamics and opportunities to guide/refine the global development and commercialization strategy.
•Oversee direct reports to ensure success in meeting PDC milestones and goals.
•Matrixed leadership of PDC team members to ensure success in meeting PDC milestones and goals.
Sanofi GenzymeGlobal Brand Lead - Rare Disease (Acid Sphingomyelinase Deficiency Disease)
Apr. 2019 - Mar. 2022Cambridge, United States• Full spectrum of initiatives related to establishing ASMD therapeutic area and the launch of olipudase alfa, (a novel ERT for treating a rare genetic disease, ASMD) and pipeline products for this disorder.
• Establish strategic direction, prioritization of resources, and alignment of cross-functional teams to ensure the execution of critical initiatives for a successful launch of new therapeutic for ASMD. These essential success factors include product supply, value creation for payers; development of a robust global evidence generation plan, stakeholder engagement, communication and dissemination of complex, nuanced product data, and ensuring a positive patient experience through patient support program.
• Lead a team of marketers and partnering with key functions including market access, HEVA, pricing, industrial affairs/manufacturing, business operations/analytics, training, regulatory/labeling, public affairs, regions, and countries.
• Accountable for leading geographic prioritization, brand strategy, product positioning, messaging, forecasts, KPI and ensuring organizational launch readiness. • Developed a high-performing team through fostering a culture of inclusiveness and patient focused centricity, encouraging colleagues to bring forward bold ideas.
Sanofi GenzymeSenior Global Marketing Director - New Product Planning (Immunology)
Jul. 2016 - Apr. 2019Cambridge, United States• Accountable for the development of commercial assessments for internal R&D projects, opt-in decisions with our partners as well as Business Development or M&A opportunities
• Development of all commercial aspects for Research-Development-Commercial process for pipeline candidates/programs to drive Global Business Unit decisions. These include GI diseases (Crohns Disease, Ulcerative Colitis), Systemic Lupus Erythematosus, Systemic Scleroderma, Idiopathic Pulmonary Fibrosis, Atopic Dermatitis, Psoriasis, Rheumatoid Arthritis; Peanut Allergy and Several Rare Diseases
o Lead the analysis of markets and opportunity assessments, including disease area; understanding, competitive landscapes, and unmet needs. o Oversee the identification of key segment business drivers, priorities, and growth opportunities.
o Identify need/timing for critical external input through expert advisors or market research
• Own Target Product Profile development. Identify and drive commercially meaningful, sustainable differentiation for candidates early in their development cycle while anticipating lifecycle management
• Ensure accurate development of forecasts—including alignment with other critical functions (e.g., Market Access & Pricing, critical regions/countries at relevant times). • Develop and defend complex commercial assumptions and OPEX scenarios.
• Contribute to Global Immunology strategic planning and execution, including opportunity assessment and due diligence of in-licensing candidates
• Provide input into clinical trial design to best impact global markets
Sanofi GenzymeGlobal Brand Lead - Multiple Sclerosis
Jul. 2012 - Jul. 2016Cambridge, United States• Led the global commercialization of Lemtrada by ensuring the development, alignment, and implementation of brand strategy across global cross-functional teams, regions, and countries.
• Built and strengthened external relationships in the KOL community to support regulatory submissions, challenging market access negotiations and ensuring message cascade to the broader HCP community.
• Led Global Marketing Team responsible for launch sequencing, differential positioning, disease and product message platforms, customer segmentation, and promotional tactics in a highly competitive market. o Held regular feedback and performance review discussions with direct reports to facilitate progress across the capabilities continuum and to develop individual performance and job satisfaction
• Partnered with market access to develop a pricing strategy that supported a unique differential dosing strategy and overall product value proposition.
• Led the implementation of impactful best in class scientific/promotional programs to educate on Lemtrada complex risk/benefit profile and highlight treatment considerations for eligible patients ensuring HCP prescribing confidence
• Developed patient support/management programs to ensure adherence to complex dosing/patient onboarding risk management plan
• Worked closely with medical affairs and research and development to ensure that key supportive initiatives in place (publication plan, Phase IV studies, and registries) and in- line with the strategy.
NovartisMarketing Director- Multiple Sclerosis- Gilenya
Jul. 2010 - Dec. 2012New Jersey, United States• Developed team responsible for launch the first oral agent in Multiple Sclerosis in the United States
• KOL development: Built and maintained data base of advocates at the national and regional levels. Developed a KOL engagement plan to ensured input gained from thought leaders on commercial strategy and activities. Reached 100% target audience with high frequency. Developed a process to monitor and track KOL engagements activities as well as outcomes.
• Professional MD and RN peer-peer and patient education programs: Conducted live speaker training meetings within a strict regulatory environment to train over 300 speakers, developed all content and worked through many issues with ethics and compliance to develop customer centric solutions whilst remaining compliant within Novartis policies. Launched several innovative programs that broke new ground at Novartis
Bayer HealthCareMarketing Director - Multiple Sclerosis
Jan. 2008 - Aug. 2010
GenentechSenior Product Manager-Avastin
Nov. 2005 - Nov. 2007
Intch is a Professional Networking App for the Future of WorkSee more people like Catherine on Intch
100k+ people
130+ countries
AI matching
Get Intch if you'd like to
51121 people
26
Digital Marketing Consultant @ Uberwood Agency
18
Administrative Assistant @ Quest Psychological and Counseling Services
16
Sr. Editor @ Global Ad Agency
17045 people
16
Pharma and healthcare analysis
15
Investor relations manager @ Exxonmobil cooperation
18
Business Analyst @ Ford Motor Company